Natera, Inc. (NTRA)
319.09
-3.85
(-1.19%)
USD |
NASDAQ |
Nov 13, 16:00
318.60
-0.49
(-0.15%)
After-Hours: 19:59
Natera Enterprise Value : 45.20B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 45.20B |
| November 12, 2026 | 45.76B |
| November 11, 2026 | 45.31B |
| November 10, 2026 | 44.17B |
| November 09, 2026 | 45.39B |
| November 06, 2026 | 43.99B |
| November 05, 2026 | 51.65B |
| November 04, 2026 | 55.58B |
| November 03, 2026 | 55.24B |
| November 02, 2026 | 53.84B |
| October 30, 2026 | 58.94B |
| October 29, 2026 | 62.08B |
| October 28, 2026 | 60.40B |
| October 27, 2026 | 58.44B |
| October 26, 2026 | 57.59B |
| October 23, 2026 | 57.45B |
| October 22, 2026 | 57.08B |
| October 21, 2026 | 58.81B |
| October 20, 2026 | 57.73B |
| October 19, 2026 | 56.80B |
| October 16, 2026 | 55.93B |
| October 15, 2026 | 57.57B |
| October 14, 2026 | 56.12B |
| October 13, 2026 | 56.25B |
| October 12, 2026 | 56.56B |
| Date | Value |
|---|---|
| October 09, 2026 | 56.98B |
| October 08, 2026 | 55.55B |
| October 07, 2026 | 56.24B |
| October 06, 2026 | 56.97B |
| October 05, 2026 | 60.58B |
| October 02, 2026 | 58.37B |
| October 01, 2026 | 58.10B |
| September 30, 2026 | 58.80B |
| September 29, 2026 | 58.68B |
| September 28, 2026 | 58.28B |
| September 25, 2026 | 58.40B |
| September 24, 2026 | 57.85B |
| September 23, 2026 | 55.27B |
| September 22, 2026 | 55.28B |
| September 21, 2026 | 52.38B |
| September 18, 2026 | 52.20B |
| September 17, 2026 | 51.75B |
| September 16, 2026 | 48.74B |
| September 15, 2026 | 49.52B |
| September 14, 2026 | 48.23B |
| September 11, 2026 | 46.39B |
| September 10, 2026 | 45.98B |
| September 09, 2026 | 46.58B |
| September 08, 2026 | 45.70B |
| September 04, 2026 | 46.28B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Guardant Health, Inc. | 21.10B |
| Myriad Genetics, Inc. | 643.96M |
| CareDx, Inc. | 3.864B |
| Caris Life Sciences, Inc. | 6.302B |
| BioRestorative Therapies, Inc. | -1.659M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -59.91M |
| Revenue (Quarterly) | 793.98M |
| Total Expenses (Quarterly) | 853.89M |
| EPS Diluted (Quarterly) | -0.4159 |
| Gross Profit Margin (Quarterly) | 63.95% |
| Profit Margin (Quarterly) | -7.55% |
| Earnings Yield | -0.36% |
| Normalized Earnings Yield | -0.3531 |